se of methylphenidate in as add on treatment in patient with Obsessve-Compulsive Disorder
- Conditions
- Health Condition 1: F422- Mixed obsessional thoughts and acts
- Registration Number
- CTRI/2024/01/061995
- Lead Sponsor
- MGM Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients with OCD disorder who fulfill the diagnostic criteria according to DSM-5.
Patient with Total score more than 16 in Yale-Brown obsessive-compulsive disorder scale.
Patients aged between 18-85 years.
Subjects who Provide written informed consent, willing and able to comply with all aspects of the protocol
Patient with prior allergic reaction on exposure to Methylphenidate
OCD patients with psychiatric illness except depression and anxiety
Substance abuse or Dependence within the past 6 months except nicotine
History of a seizure disorder or other major neurologic disease.
Patients with psychiatric Instability that made participants potentially unsafe in the evaluating psychiatrists judgment.
Patients with pregnancy or breastfeeding
Patients with known chronic medical illness like, Diabetes Mellitus, Hypertension, Cerebro-vascular Accident, Ischemic Heart Disease, Coronary Artery Disease etc.
Patients not in a condition to give written informed consent E.g.: Delirium, intellectual disability etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method